Back to McKinsey Chart of the Day

Make way for new players

In 2020, some 70 percent of new clinical trials were sponsored by smaller pharma companies, up from 60 percent in 2016. Unprecedented levels of venture-capital investment and increasing availability and breadth of outsourced capacity and capabilities paved the way for smaller companies to pursue innovation.

Make way for new players
We strive to provide individuals with disabilities equal access to our website. If you would like information about this content we will be happy to work with you. Please email us at: McKinsey_Website_Accessibility@mckinsey.com

To read the article, see “Building pharma pipelines using a socioeconomic lens,” April 8, 2022.